Home

ELIAS VAMVAKAS

CIK 1061865 · Chairman · last filed 2020-07-10

ELIAS VAMVAKAS is a Chairman who has filed 30 SEC Form 4 insider transactions across 4 companies since 2007. Across all open-market trades the lifetime net is −$10.1M, making them a net seller over the disclosed history. 28 SEC filings were submitted jointly with TLC VISION CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

30

Lifetime Open-Market Net

-$10.09M

Filer Profile

Reported Address
5280 SOLAR DRIVE
SUITE 100
MISSISSAUGA, A6 L4W 5M8
Related Filers
TLC VISION CORP — 28 joint filings, latest 2008-01-29
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TearLab Corp (TEAR) Delisted Chairman 52,140 — — $1.73M 21 2016-06-28
TearLab Corp (OCCXD) Delisted Chairman of the Board — — — $0 1 2008-10-20
TearLab Corp (OCCX) Delisted Chairman of the Board 76,190 — — $2.00M 3 2008-10-08
TLC VISION CORP (TLCV) Delisted Director 3,816,855 — — -$13.83M 4 2007-06-28

Recent Filings

30 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-07-10 — U −182,953 -$10.7K
2016-06-28 TearLab Corp (TEAR) Delisted Grant (A) — $0 EDGAR
2014-12-05 TearLab Corp (TEAR) Delisted Buy (P) +50,000 $112.1K EDGAR
2014-11-19 TearLab Corp (TEAR) Delisted Buy (P) +31,187 $79.5K EDGAR
2014-11-18 TearLab Corp (TEAR) Delisted Buy (P) +18,813 $47.9K EDGAR
2014-11-12 TearLab Corp (TEAR) Delisted Buy (P) +150,000 $374.1K EDGAR
2014-11-12 TearLab Corp (TEAR) Delisted Buy (P) +70,000 $240.0K EDGAR
2014-08-13 TearLab Corp (TEAR) Delisted Buy (P) +70,000 $240.0K EDGAR
2013-06-12 TearLab Corp (TEAR) Delisted Mixed +56,000 -$89.3K EDGAR
2013-03-08 TearLab Corp (TEAR) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 30
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.